Bill > HB186

This bill creates new provisions in Missouri state law to regulate insulin costs for health insurance policies. Specifically, the bill requires health insurers to limit an insured person's out-of-pocket costs for a thirty-day supply of prescription insulin drugs to $100, starting August 28, 2025. The $100 cap will be indexed to increase annually based on the medical care component of the Consumer Price Index. The bill defines "prescription insulin drug" as an insulin medication used to control blood glucose levels for diabetes treatment, excluding intravenous insulin. Additionally, the bill mandates that before November 2, 2025, the departments of commerce and insurance, health and senior services, and social services must produce a public report detailing insulin pricing practices, recommending public policies to prevent insulin drug overpricing, and providing other relevant information. The reporting requirement will automatically expire on January 1, 2026. The legislation also authorizes the director of the department of commerce and insurance to create necessary regulations for implementing these provisions, with specific guidelines about rule-making procedures.

https://house.mo.gov/Bill.aspx?bill=HB186&year=2025&code=R